The pharmacokinetics of carbamazepine
- 1 January 1977
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 12 (6), 451-456
- https://doi.org/10.1007/bf00561065
Abstract
The time-courses of plasma carbamazepine concentrations were followed in six apparently healthy adult subjects who, at different times, took single oral drug doses of 200, 400, 500, 600, 700, 800 and 900 mg. There were some suggestions of impaired bioavailability of the drug when given in tablet form. The following values were obtained for various pharmacokinetic parameters:k abs =0.176±0.209 h−1;k=0.0203±0.0055 h−1; T1/2=37.5±13.1 h; VD=0.825±0.1041 · kg−1; Clearance=0.0163±0.0061 l · kg−1. The elimination rate constant showed a statistically significant increase with increasing drug dose. This may help explain the clinical observation that the rate of rise of steady state plasma carbamazepine concentrations tends to decrease with dose increase in patients taking carbamazepine alone.Keywords
This publication has 7 references indexed in Scilit:
- Factors influencing plasma carbamazepine concentrations.1977
- Pharmacokinetics of carbamazepine in normal humans after single and repeated oral dosesJournal of Pharmacokinetics and Biopharmaceutics, 1976
- Pharmacokinetics of carbamazepine in normal manClinical Pharmacology & Therapeutics, 1975
- Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple dosesEuropean Journal of Clinical Pharmacology, 1975
- Distribution and elimination kinetics of carbamazepine in manEuropean Journal of Clinical Pharmacology, 1975
- Preliminary observations on the clinical pharmacology of carbamazepine ('Tegretol').1974
- Quantitative assay for carbamazepine serum levels by gas-liquid chromatographyClinica Chimica Acta; International Journal of Clinical Chemistry, 1973